Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTN3A1 | O00481 | 8/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.30 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.30 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.30 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.30 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.30 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.30 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL803816 | 0.84 | — | — | |
| SCHEMBL196185 | 0.84 | — | — | |
| SCHEMBL10666 | 0.84 | — | — | |
| Phosphoric Acid SCHEMBL7261093 | 0.71 | ALDH1A1 (0.41) | BTN3A1CA2 | |
| Phosphoric Acid SCHEMBL2933082 | 0.71 | ALDH1A1 (0.41) | BTN3A1CA2 | |
| SCHEMBL6853741 | 0.71 | — | — | |
| Phosphoric Acid SCHEMBL1401540 | 0.70 | CA2 (0.43) | BTN3A1CA2 | |
| Phosphoric Acid SCHEMBL5963649 | 0.70 | CA2 (0.43) | BTN3A1CA2 | |
| Phosphoric Acid SCHEMBL28390234 | 0.69 | CA2 (0.35) | BTN3A1CA2 | |
| Phosphoric Acid SCHEMBL721013 | 0.67 | CA2 (0.40) | BTN3A1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 290 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260117135-A1 | SYSTEMS AND METHODS FOR PRODUCING A DIMETHYLCYCLOOCTANE-BASED AVIATION FUEL FROM ISOPRENE | CleanJoule, Inc. (US) | 2026-04-30 | — | — | US | claimed |
| US-11981945-B2 | Process of producing monoterpenes | C3 BIOTECHNOLOGIES LIMITED (GB) | 2024-05-14 | — | — | US | claimed |
| US-20230332165-A1 | MARKER COMPOSITION FOR SELECTING LIVING MODIFIED ORGANISM, LIVING MODIFIED ORGANISM, AND TRANSFORMATION METHOD | INDUSTRY-ACADEMIC COOPERATION FOUNDATION GYEONGSANG NATIONAL UNIVERSITY (KR) | 2023-10-19 | — | — | US | claimed |
| US-20230183653-A1 | METHOD FOR PRODUCING STEM CELLS AND METHOD FOR PRODUCING SOMATIC CELLS | I PEACE, INC. (US) | 2023-06-15 | — | — | US | claimed |
| WO-2023053994-A1 | METHOD FOR PRODUCING STEM CELLS | アイ ピース， インコーポレイテッド | 2023-04-06 | — | — | WO | claimed |
| US-11549117-B2 | Marker composition for selecting living modified organism, living modified organism, and transformation method | INDUSTRY-ACADEMIC COOPERATION FOUNDATION GYEONGSANG NATIONAL UNIVERSITY (KR) | 2023-01-10 | — | — | US | claimed |
| US-20200199602-A1 | MARKER COMPOSITION FOR SELECTING LIVING MODIFIED ORGANISM, LIVING MODIFIED ORGANISM, AND TRANSFORMATION METHOD | INDUSTRY-ACADEMIC COOPERATION FOUNDATION GYEONGSANG NATIONAL UNIVERSITY (KR) | 2020-06-25 | — | — | US | claimed |
| EP-3623480-A1 | MARKER COMPOSITION FOR SELECTING LIVING MODIFIED ORGANISM, LIVING MODIFIED ORGANISM, AND TRANSFORMATION METHOD | Industry-Academic Cooperation Foundation Gyeongsang National University (KR) | 2020-03-18 | — | — | EP | claimed |
| US-9175330-B2 | Method for screening and quantifying isoprene biosynthesis enzyme activity | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2015-11-03 | — | — | US | claimed |
| WO-2014129808-A1 | METHOD FOR SCREENING AND QUANTIFYING ISOPRENE BIOSYNTHESIS ENZYME ACTIVITY | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2014-08-28 | — | — | WO | claimed |
| US-20140235502-A1 | METHOD FOR SCREENING AND QUANTIFYING ISOPRENE BIOSYNTHESIS ENZYME ACTIVITY | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2014-08-21 | — | — | US | claimed |
| WO-2011034397-A2 | METHOD FOR PREDICTING DRUG TARGETS AND SCREENING FOR DRUGS FOR PATHOGENIC MICROORGANISMS USING ESSENTIAL METABOLITES | 한국과학기술원 (KR) | 2011-03-24 | — | — | WO | claimed |
| US-20080318227-A1 | Intermediates and enzymes of the non-mevalonate isoprenoid pathway | BACHER ADELBERT | 2008-12-25 | — | — | US | claimed |
| US-7297509-B2 | Intermediates and enzymes of the non-mevalonate isoprenoid pathway | Bacher, Adelbert (DE) | 2007-11-20 | — | — | US | claimed |
| US-20040176570-A1 | Intermediates and enzymes of the non-mevalonate isoprenoid pathway | ROHDICH, FELIX (DE) | 2004-09-09 | — | — | US | claimed |
| EP-1377663-A2 | INTERMEDIATES AND ENZYMES OF THE NON-MEVALONATE ISOPRENOID PATHWAY | Bacher, Adelbert (DE) | 2004-01-07 | — | — | EP | claimed |
| WO-2002083720-A2 | INTERMEDIATES AND ENZYMES OF THE NON-MEVALONATE ISOPRENOID PATHWAY | BACHER ADELBERT (DE) | 2002-10-24 | — | — | WO | claimed |
| US-20260117263-A1 | GENETICALLY ENGINEERED PEPTIDE SUPERSTRUCTURE AND MICROBE FOR PRODUCTION OF ISOPRENE AND METHOD OF PRODUCTION THEREOF | CleanJoule, Inc. (US) | 2026-04-30 | — | — | US | disclosed |
| WO-2002083720-A2 | INTERMEDIATES AND ENZYMES OF THE NON-MEVALONATE ISOPRENOID PATHWAY | BACHER ADELBERT (DE) | 2002-10-24 | — | — | WO | disclosed |
| US-20020069426-A1 | Methyl-D-erythritol phosphate pathway genes | MONSANTO TECHNOLOGY, L.L.C. | 2002-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260117263-A1 | GENETICALLY ENGINEERED PEPTIDE SUPERSTRUCTURE AND MICROBE FOR PRODUCTION OF ISOPRENE AND METHOD OF PRODUCTION THEREOF | FDPS, COASY, DHPS | BTN3A1 3611/4885CA2 3106/4885GRIN2D 3627/4885 |
| US-20260117135-A1 | SYSTEMS AND METHODS FOR PRODUCING A DIMETHYLCYCLOOCTANE-BASED AVIATION FUEL FROM ISOPRENE | ERG28, DIMT1, MSMO1 | BTN3A1 4591/4885CA2 1069/4885GRIN2D 4523/4885 |
| US-20040176570-A1 | Intermediates and enzymes of the non-mevalonate isoprenoid pathway | FDPS, DHPS, COASY | BTN3A1 3513/4885CA2 3814/4885GRIN2D 3832/4885 |
| US-20080318227-A1 | Intermediates and enzymes of the non-mevalonate isoprenoid pathway | FDPS, DHPS, COASY | BTN3A1 3402/4885CA2 3772/4885GRIN2D 4014/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.